July 9, 2026 Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
July 9, 2026 Aoman Future Advances Last-Mile Delivery Robots with Multi-Sensor Fusion SLAM and Cloud Cluster Scheduling
July 9, 2026 Five Leading Laryngoscope Manufacturers in China 2026: Innovating Visual Intubation Medical Equipment
